Abnormal interbrain coupling in individuals with childhood adversity may underlie their difficulties in benefiting from social interactions
Journal of Affective Disorders · 2025
DOI: 10.1016/j.jad.2025.02.050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von Yarden Avnor und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, University of Haifa, Israel. Electronic address: avnory@gmail.com. Hauptthemen laut MEDLINE: Adverse Childhood Experiences, Social Interaction, Prefrontal Cortex, Brain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Horizon 2020, Israel Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychology, University of Haifa, Israel. Electronic address: avnory@gmail.com.
- Department of Psychology, University of Haifa, Israel; The Integrated Brain and Behavior Research Center (IBBRC), Israel.
Förderung
- European Research Council
- Horizon 2020
- Israel Science Foundation
Zitieren
APA
Avnor, Y., & Shamay-Tsoory, S. (2025). Abnormal interbrain coupling in individuals with childhood adversity may underlie their difficulties in benefiting from social interactions. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.02.050
Vancouver
Avnor Y, Shamay-Tsoory S. Abnormal interbrain coupling in individuals with childhood adversity may underlie their difficulties in benefiting from social interactions. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2025.02.050
BibTeX
@article{Avnor2025,
author = {Avnor, Yarden and Shamay-Tsoory, Simone},
title = {Abnormal interbrain coupling in individuals with childhood adversity may underlie their difficulties in benefiting from social interactions},
journal = {Journal of Affective Disorders},
year = {2025},
doi = {10.1016/j.jad.2025.02.050}
}
EUVIMED